Dunaieva, I.P. “Liraglutide As a Means of Modifying Cardiometabolic Risk in Patients With Arterial Hypertension and Concomitant Obesity”. Inter Collegas 12, no. 2 (April 1, 2025). Accessed June 27, 2025. https://inter.knmu.edu.ua/article/view/10.35339.ic.2025.12.2.dun.